Pneumonia in the elderly
1Service de Médicine Interne, Hôpital Bichat, Paris, France.
Abstract:
Pneumonia is the leading cause of death due to infectious disease in the elderly and the fourth most common cause of death overall. Streptococcus pneumoniae remains the main aetiological agent in community-acquired pneumonia. Aspiration pneumonia related to neuromuscular disease is also a frequent event. Pneumonia is the second most frequent hospital-acquired infection in long-term care facilities. For community-acquired pneumonia, initial therapy is most often empirical but invasive diagnostic tests may be required if signs of severity are present. Broad-spectrum coverage is usually required using a second- or third-generation cephalosporin and only in the case of failure are invasive investigations necessary. Aspiration pneumonia may be treated with a combination of a beta-lactam and a beta-lactamase inhibitor. Initial therapy of nosocomial infections is based upon the susceptibility pattern of bacteria identified.
Insights
Pneumonia is a major infectious cause of death, especially in the elderly. Treatment for community-acquired pneumonia is often empirical, with invasive tests reserved for severe cases.
Area of Science:
- Infectious Diseases
- Geriatrics
- Pulmonology
Background:
- Pneumonia is a leading cause of death from infectious disease in the elderly.
- Streptococcus pneumoniae is the primary cause of community-acquired pneumonia.
- Aspiration pneumonia is common in patients with neuromuscular disease.
Purpose of the Study:
- To review current approaches to pneumonia diagnosis and treatment.
- To highlight the importance of empirical therapy for community-acquired pneumonia.
- To discuss treatment strategies for aspiration pneumonia and nosocomial infections.
Main Methods:
- Review of existing literature on pneumonia epidemiology and treatment.
- Analysis of common etiological agents and risk factors.
- Discussion of therapeutic guidelines for different pneumonia types.
Main Results:
- Community-acquired pneumonia often requires empirical broad-spectrum antibiotic coverage.
- Invasive diagnostic tests are indicated for severe community-acquired pneumonia cases.
- Aspiration pneumonia treatment may involve beta-lactam/beta-lactamase inhibitor combinations.
Conclusions:
- Prompt and appropriate treatment is crucial for managing pneumonia, particularly in vulnerable populations.
- Tailoring therapy based on bacterial susceptibility is key for nosocomial infections.
- Understanding causative agents and risk factors guides effective pneumonia management.
Related Concept Videos
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: